Form D · Biotechnology

NuShores Biosciences LLC

Little Rock, AR · CIK 0001704519

Offering snapshot reported Mar 1, 2022 · SEC filing

Reported sold: $1.5M
Investors reported: 4
Minimum accepted: $50K
First sale: Jul 24, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$250,000 → $1,500,000
Reported investors1 → 4
Minimum accepted$250,000 → $50,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 1, 2022	Amendment	$1,500,000	$1,250,000vs Aug 4, 2020	4	SEC filing
Aug 4, 2020	Initial	$250,000	No comparison	1	SEC filing
Jan 9, 2019	Amendment	$1,100,000	$700,000vs Apr 19, 2018	8	SEC filing
Apr 19, 2018	Amendment	$400,000	$300,000vs May 1, 2017	6	SEC filing
May 1, 2017	Initial	$100,000	No comparison	1	SEC filing

Offering details

Securities: Equity, Other
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-372412

Simple Agreement for Future Equity

Source: Form D, filed Mar 1, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sharon Ballard	Director, Executive
Alex Biris	Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

4623 Crestwood Drive
Little Rock, AR, 72207